| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |